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Introduction
For decades, America’s healthcare system has kept price and
quality information secret from the patients who need it.
Healthcare experts all across the political spectrum have long
agreed this has to change.1
– Alex Azar, Secretary of Health and Human Services
It is no secret that the United States has significantly higher health
care prices compared to the rest of the world.2 American patients and
insurance companies pay higher prices for basic health visits,
pharmaceutical drugs, medical tests, and common procedures.3
Consumers often cannot find cost estimates for medical services before
care delivery, and providers usually do not offer accurate price
estimations.4 The increasing health care prices, in addition to
undisclosed or imprecise cost estimates, make lowering health care costs
a pressing but difficult national issue.5 The United States’ federal
government and individual state governments are currently considering
bills and passing laws to address health care costs and require price
transparency.6

1.

HHS Secretary Statement on Executive Order to Put Patients in Control,
U.S. DEP’T OF HEALTH & HUMAN SERV. (June 24, 2019),
https://public3.pagefreezer.com/browse/HHS.gov/31-12-2020T08:51/
https://www.hhs.gov/about/news/2019/06/24/statement-executiveorder-to-put-patients-in-control.html [https://perma.cc/D8RA-652B].

2.

See 2017 Comparative Price Report, INT’L FED’N OF HEALTH PLANS (Dec.
2019),
https://healthcostinstitute.org/images/pdfs/iFHP_Report_
2017_191212.pdf [https://perma.cc/PQ4Z-G9GE].

3.

Margot Sanger-Katz, In the U.S., an Angioplasty Costs $32,000.
Elsewhere? Maybe $6,400., N.Y. TIMES, (Dec. 27, 2019),
https://www.nytimes.com/2019/12/27/upshot/expensive-health-careworld-comparison.html [https://perma.cc/3APA-DLTV].

4.

Jacqueline LaPointe, Price Transparency a Key Way States Control
Healthcare
Costs, REVCYCLEINTELLIGENCE,
(Aug.
27,
2019),
https://revcycleintelligence.com/news/price-transparency-a-key-waystates-control-healthcare-costs [https://perma.cc/Q3C6-59VZ].

5.

See Sanger-Katz, supra note 3.

6.

See Jacqueline LaPointe, Few States Have Robust Healthcare Price
11,
2020),
Transparency
Laws, REVCYCLEINTELLIGENCE (May
https://revcycleintelligence.com/news/few-states-have-robusthealthcare-price-transparency-laws
[https://perma.cc/8UYZ-D23P];
Transparency of Health Costs: State Actions, NAT’L CONF. OF STATE
LEGS., https://www.ncsl.org/research/health/transparency-anddisclosure-health-costs.aspx
[https://perma.cc/6FAF-FXHP];
Jim
Stergios & Charlie Chieppo, Health Care Price Transparency Bill Would
Be a Win For Taxpayers, Employers and Consumers, HILL (July 21, 2020
6:00 EDT), https://thehill.com/blogs/congress-blog/healthcare/508417-
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As the United States’ health care expenditures continue to surge
annually,7 price transparency has become a priority. Most American
patients are unaware of what costs their insurance covers and what
costs they must personally pay.8 These patients do not learn the cost
amounts until the time of payment, making it difficult for them to make
autonomous health care decisions.9 To combat this, the federal and
state governments are trying to advance price transparency so that
Americans may be the drivers of their health care treatment.10 For
example, President Trump issued an executive order to emphasize the
need to develop health care price transparency for patients.11 In
addition, the Centers for Medicare and Medicaid also finalized rules,
requiring hospitals and insurance companies to publish their retail
prices online for patients.12 Moreover, several states passed laws to
implement all-payer claims databases (APCDs), which collect health
care pricing information to post on public websites.13 Nevertheless, there
are disagreements among hospitals, economists, and other experts as to
whether these various laws increase price transparency in a way that
enables patients to compare prices and lower health care costs.14
health-care-price-transparency-would-be-a-win-for-taxpayers
[https://perma.cc/AH76-UB33].
7.

National Health Expenditure Fact Sheet, CTRS. FOR MEDICARE &
MEDICAID (Dec. 5, 2019, 6:18 PM), https://www.cms.gov/ResearchStatistics-Data-and-Systems/Statistics-Trends-and-Reports/National
HealthExpendData/NHE-Fact-Sheet [https://perma.cc/H8C9-2DSP].

8.

See Josh Archambault, Price Transparency Will Deliver Real Results for
Patients, FORBES (July 12, 2019, 12:20 PM), https://www.forbes.com/
sites/theapothecary/2019/07/12/realresults/#15c40f6f26e1
[https://perma.cc/F8X9-5XU4].

9.

Id.

10.

See id.

11.

See Exec. Order No. 13877, 84 Fed. Reg. 30,849 (June 24, 2019).

12.

Billy Wynne et al., A Look Inside The Hospital Transparency Final Rule,
HEALTH AFFAIRS (Nov. 18, 2019), https://www.healthaffairs.org/
do/10.1377/hblog20191118.74200/full/ [https://perma.cc/879L-SQV5];
CTRS. FOR MEDICARE & MEDICAID SERVS., CMS-9915-F, TRANSPARENCY
IN COVERAGE FINAL RULE FACT SHEET (2020).

13.

Roslyn Murray et al., The State of State Legislation Addressing Health
Care
Costs
and
Quality, HEALTHAFFAIRS (Aug.
22,
2019),
https://www.healthaffairs.org/do/10.1377/hblog20190820.483741/full/
[https://perma.cc/T5G4-CERG].

14.

See Thomas Sullivan, New Research Paper Indicates Price Transparency
May Not Equate to Lower Prices, POL’Y & MED. (Aug. 26, 2020),
https://www.policymed.com/2020/09/new-research-paper-indicatesprice-transparency-may-not-equate-to-lower-prices.html
[https://perma.cc/642K-9EDB]; Benjamin Schwartz, The Problem With
Pushing for Price Transparency, OP-MED (Feb. 18, 2020)
https://opmed.doximity.com/articles/the-problem-with-pushing-forprice-transparency [https://perma.cc/B4S5-UARC]; Sarah Kliff &
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This Note proposes a new cost estimation system involving health
care clearinghouses to act as translators between providers and payers.
Clearinghouses may present each patient with an individualized,
bundled cost estimate, combining all item and service costs as one
estimate, prior to the patients receiving non-emergent medical care. A
cost estimation system with clearinghouses has the potential to improve
price transparency. This Note argues that price transparency laws are
effective in protecting patients from high health care costs and allowing
patients to make informed health care decisions as patients may
evaluate cost estimates before any non-emergent medical treatment.
Part II analyzes the effects of price transparency on the patients
and health care prices. Part III provides background on federal efforts
to reduce health care costs and encourage price transparency. Part IV
discusses states’ use of all-payer claims databases to offer consumerfriendly access to health care prices. Part V recommends a systematic
process involving health care clearinghouses to improve price
transparency among providers, payers, and patients. Finally, Part VI
concludes clearinghouses as a tool to strengthen health care price
transparency.

I. Background on Health Care Price Transparency
The Centers for Medicare and Medicaid Services (CMS) projects
that the United States’ health spending will grow at an average rate of
5.5% annually, reaching nearly $6 trillion by 2027.15 In 2018, the United
States’ health expenditures grew by 4.6% to $3.6 trillion, accounting
for 17.7% of the country’s gross domestic product (GDP).16 These
statistics illustrate the urgency to evaluate and decelerate health care
costs.
Congress passed the Patient Protection and Affordable Care Act
(ACA) in 2010 to expand the number of insured American health care

Margot Sanger-Katz, Hospitals Sued to Keep Prices Secret. They Lost.,
N.Y. TIMES (June 23, 2020), https://www.nytimes.com/2020/
06/23/upshot/hospitals-lost-price-transparency-lawsuit.html
[https://perma.cc/G9RN-NMPV];
Hannah
Nelson, AHIP
Issues
Criticism on Final CMS Price Transparency Rule, HEALTH PAYER
INTELLIGENCE (Nov.
5,
2020), https://healthpayerintelligence.com/
news/ahip-issues-criticism-on-final-cms-price-transparency-rule
[https://perma.cc/J6XZ-3NT3].
15.

CTRS. FOR MEDICARE & MEDICAID SERVS.,
EXPENDITURE PROJECTIONS 2018–2027 (2019).

16.

Press Release, Ctrs. for Medicare & Medicaid Servs., CMS Office of the
Actuary Releases 2018 National Health Expenditures (Dec. 5, 2019),
https://www.cms.gov/newsroom/press-releases/cms-office-actuaryreleases-2018-national-healthexpenditures#:~:text=The%20growth
%20in%20total%20national,experienced%20faster
%20growth%20in%202018 [https://perma.cc/9D6D-QF2P].
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consumers while improving health insurance affordability.17 However,
President Obama emphasized that expanding insurance coverage
without addressing the increasing healthcare costs would create an
unsustainable healthcare system because federal and state governments
would become bankrupt.18 The rising health care costs lay emphasis on
the need for government intervention and price transparency.
A.

Effects of Price Transparency on Costs and Patients

Price transparency exists when consumers have all the information
concerning a good’s pricing.19 This also means there is no price
discrimination in which different consumers are charged different
prices.20 When price information is transparent, consumers know what
they are expected to pay. Then, consumers can make sound cost
comparisons of alternative options.21 Transparent prices are important
to create an ideally free market with an efficient allocation of goods and
services.22 Price transparency and cost comparisons pressure sellers to
compete, and the increased competition may lower prices.23 If buyers
can access and compare prices for the same good offered by different
sellers, then the buyers may save money by selecting the cheaper
product.24 If goods are similar but not the same, price transparency
allows buyers to compare and buy what best suits them.25 Without
market competition, sellers that are less efficient or earning excess
profits can remain in the market, and prices remain higher than they
would be if the market was competitive and efficient.26
Health care price transparency provides consumers the ability to
access provider-specific information on the prices of goods and services.
Generally, health care consumers are particularly interested in out-ofpocket costs because price transparency is not effective if patients
consider irrelevant prices such as list prices, which are the costs before
17.

Christopher Limbacher, Healthcare Price Transparency: Reintroducing
Competition, 53 HOUS. L. REV. 939, 941 (2016).

18.

Id. at 942.

19.

See D. ANDREW AUSTIN & JANE G. GRAVELLE, CONG. RESEARCH SERV.,
RL34101, DOES PRICE TRANSPARENCY IMPROVE MARKET EFFICIENCY?
IMPLICATIONS OF EMPIRICAL EVIDENCE IN OTHER MARKETS FOR THE
HEALTH SECTOR 1 (2007).

20.

Uwe E. Reinhardt, Health Care Price Transparency and Economic
Theory, 312 JAMA 1642, 1642 (2014).

21.

AUSTIN & GRAVELLE, supra note 19.

22.

Id.

23.

Id.

24.

Id.

25.

Id.

26.

Id.
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insurance companies cover a percentage.27 Out-of-pocket costs are the
prices patients pay after the provider charges the insurance company,28
and most American patients do not know their out-of-pocket costs until
the time of payment.29 Therefore, they are unable to make cost-based
health care decisions. Patients need good-faith, out-of-pocket price
estimates before receiving treatment.30
B.

Support for Price Transparency

Advocates believe patients deserve transparent health care pricing,
and transparency is a solution to address the increasing health care
expenditures. The main argument for increasing price transparency is
that it will promote consumer-directed health care.31 If American
patients are adequately informed, they may be able to better navigate
the health care system and spend less money.32 Because most patients
do not know the cost of their medical care until the time of payment,
they are unable to make thoughtful, informed health care decisions.33
According to national surveys, Americans want more information about
prices while health care industry players are withholding information
and resisting disclosure.34 Eighty-two percent of surveyed American
voters claimed that they wished to know the cost of non-emergency
procedures ahead of time.35 The questions that remain open are whether
price transparency lowers health care costs and whether patients will
understand the data.
The patients who use the publicly-available pricing information and
shop for services can save money and create “spillover effects” for other
consumers.36 Price transparency tools generate “spillover effects” when
consumers who did not shop for health care reap the benefits of lowered
27.

See Austin Frakt & Ateev Mehrotra, What Type of Price Transparency
Do We Need in Health Care?, 170 ANNALS OF INTERNAL MED. 561, 561–
62 (2019).

28.

Out-of-Pocket Costs, HEALTHCARE.GOV, https://www.healthcare.gov/
glossary/out-of-pocket-costs/ [https://perma.cc/M8WP-R3C4].

29.

LaPointe, supra note 4.

30.

Frakt & Mehrotra, supra note 27, at 562.

31.

See Reinhardt, supra note 20.

32.

Id. at 1643.

33.

Archambault, supra note 8.

34.

Id.

35.

Poll: Voters Want the Right to Shop for Health Care, FOUND. FOR GOV’T
ACCOUNTABILITY (Jan. 29, 2018), https://thefga.org/poll/right-to-shoppoll/ [https://perma.cc/7HYN-3X4R].

36.

See Brian Blase, How Price Transparency Would Revolutionize
Healthcare, N.Y. POST (Oct. 12, 2019 1:05 PM), https://nypost.com/
2019/10/12/how-price-transparency-would-revolutionize-healthcare/
[https://perma.cc/NNS6-5ZFT].
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prices created by those who shopped for services.37 For example, New
Hampshire has a website that displays prices for medical services such
as medical imaging, and individuals who shopped on the website saved
about thirty-six percent of what the costs they would have paid if they
had not used the website to compare prices.38 If more consumers become
shoppers who evaluate the prices for medical services, expensive
facilities will lower prices.39
Most price transparency tools publish average or median hospital
prices for individual services, which are not out-of-pocket costs.40
Consumers must actively consider medical care prices in their
decisions.41 A group of researchers studied consumers’ responses to price
transparency, and the results confirmed that price transparency may
increase competition and decrease health care costs if consumers are
given strong financial incentives for price shopping.42 The researchers
found that published health care prices alone produce limited success
in terms of price shopping and increased competition.43 Patients need
financial incentives to encourage them to price shop.44 On the other
hand, if the costs to find and interpret data are high, then consumers
have little incentive to compare costs.45 This research suggests that
price transparency has the potential to increase competition and lower
health care costs if patients are provided with incentives to assess health
care prices.
Lastly, health care price transparency advocates argue that
providers and patients have a joint ethical responsibility to discuss
medical costs to avoid financial harm to society.46 As the United States
continues to endure rising health care costs, it would be unethical for
physicians to allow patients to carry heavy financial health care
burdens.47 Therefore, published cost data can improve price
37.

Id.

38.

Id.

39.

Id.

40.

Anna D. Sinaiko & Meredith B. Rosenthal, Increase Price Transparency
in Health Care – Challenges and Potential Effects, 364 NEW ENG. J. OF
MED. 891, 891 (2011).

41.

Id. at 893.

42.

Christopher Whaley et al., Consumer Responses to Price Transparency
Alone Versus Price Transparency Combined With Reference Pricing, 5
AM. J. OF HEALTH ECON. 227, 227 (2019).

43.

Id. at 246.

44.

Id.

45.

Id.

46.

Reshma Gupta et al., Promoting Transparency to Reduce Financial Harm
to Patients, 17 AM. MED. ASS’N. J. OF ETHICS 1073, 1075 (2015).

47.

Id.
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transparency and help avoid financial harm while promoting ethical
medical practice.48 The promotion of price transparency to deliver highquality health care at lower costs is arguably part of physicians’ ethical
duty to patients.49
C.

Criticism of Price Transparency

Several critics argue against health care price transparency because
patients rarely use price transparency tools.50 The American Journal of
Managed Care published a study that surveyed more than 140 million
health plan members across 31 different commercial plans who had
access to price transparency tools.51 The researchers found that only
two percent used the tools.52 They concluded that access to pricing tools
does not increase the likelihood of using the tool, nor does it necessarily
lead to lower costs.53 Thus, the researchers suggested additional inquiry
to identify ways to better engage consumers and motivate them to make
more informed and cost-effective decisions regarding their health care.54
Another study investigated the relationship between employer-provided
price information and outpatient spending.55 The Harvard Medical
School researchers found that employees rarely used the provided
information.56 Consequently, the researchers did not observe a reduction
in health care costs.57 The rare use of price transparency tools supports
critics’ claims that price transparency will not decrease health care
costs.58

48.

Id.

49.

Id.

50.

Jacqueline LaPointe, How Healthcare Price Transparency Can Cuts
Costs, Improve Value, REVCYCLEINTELLIGENCE (Sept. 4, 2019),
https://revcycleintelligence.com/news/how-healthcare-pricetransparency-can-cuts-costs-improve-value
[https://perma.cc/99V6NPBU].

51.

Aparna Higgins et al., Characterizing Health Plan Price Estimator Tools:
Findings From a National Survey, 22 AM. J. OF MANAGED CARE 126, 127
(2016).

52.

Id. at 130.

53.

Id.

54.

Id. at 131.

55.

See Sunita Desai et al., Association Between Availability of a Price
Transparency Tool and Outpatient Spending, 315 JAMA 1874 (2016).

56.

Id. at 1879.

57.

Id.

58.

See Rebecca A. Gourevitch et al., Who Uses a Price Transparency Tool?
Implications for Increasing Consumer Engagement, 54 J. OF HEALTH
CARE ORG., PROVISION, AND FINANCING 1–5 (2017).
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Some argue that health care price transparency will ultimately
increase costs.59 While economic theories suggest increasing price
transparency will decrease health care costs, health care is considered
an unusual economic sector that potentially disobeys economic rules.60
Peter Ubel, a physician and behavioral scientist at Duke University,
explained that public price information will enable providers to observe
that competitors are charging higher prices, so providers may respond
by raising their prices.61 Currently, most hospitals determine prices
through confidential negotiations with insurers.62 If the negotiated
prices become publicly available, providers will learn the prices charged
by competitors.63 In other industries, similar transparency interfered
with contract negotiations and caused higher prices, so there is concern
that health care price transparency may produce a parallel effect.64
Furthermore, price transparency tools may be considered ineffective
because consumers misinterpret the provided information. A survey
found that approximately half of the American population believes that
higher quality health care generally comes at a higher cost while thirtyseven percent claim there is no real relationship between quality and
cost.65 Because some Americans believe that higher costs equate to
higher quality, they are more likely to select higher-priced health care.66
The implementation of price information tools may cause unintended
higher prices because patients may intentionally opt for more expensive
care.

59.

See Peter Ubel, How Price Transparency Could End Up Increasing
Health-Care
Costs,
ATLANTIC
(Apr.
9,
2013),
https://www.theatlantic.com/health/archive/2013/04/how-pricetransparency-could-end-up-increasing-health-care-costs/274534/
[https://perma.cc/M3WZ-AGFV] (explaining how “[p]rice transparency
may also cause prices to rise by reducing health-care providers’ willingness
to bargain with insurance companies.”).

60.

David Blumenthal et al., Price Transparency in Health Care is Coming
to the U.S. – But Will it Matter?, HARV. BUS. REV. (July 3, 2019),
https://hbr.org/2019/07/price-transparency-in-health-care-is-coming-tothe-u-s-but-will-it-matter [https://perma.cc/G6QL-99VL].

61.

Ubel, supra note 59.

62.

Anna D. Sinaiko, What Is the Value of Market-Wide Health Care Price
Transparency?, 322 J. OF AM. MED. ASS’N 1449, 1449 (2019).

63.

Id.

64.

Id.

65.

THE ASSOCIATED PRESS NAT’L OPINION RES. CTR., FINDING QUALITY
DOCTORS: HOW AMERICANS EVALUATE PROVIDER QUALITY IN THE UNITED
STATES (2014), https://apnorc.org/wp-content/uploads/2020/02/Finding
-Quality-Doctors-Research-Highlights.pdf
[https://perma.cc/55LW3HHJ].

66.

Blumenthal et al., supra note 60.
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Additionally, as previously noted, patients are only concerned
about out-of-pocket payments.67 For instance, two different patients
paying for the same medical test may both pay $150 out-of-pocket
although each individual’s insurance company may cover different
amounts. If patients are paying the same out-of-pocket price, they do
not have any incentive to compare or shop for another medical test that
is cheaper based on list pricing.68
Several analysts are skeptical regarding the possible effects of price
transparency because they fear hospital prices may become lower, but
the costs will shift elsewhere.69 If health care costs shift from hospital
charges to payments for insurance, consumers will still pay for the
redistributed health care costs.70 In other words, consumers may pay
less for hospital charges but more for insurance coverage. Others
question whether hospital-provided health care is shoppable because
patients often do not have incentives to consider different providers.71
Patients typically trust their doctors’ opinions and orders, so they
would not have an incentive to obtain a second opinion, especially for
non-emergent or routine medical services. Critics generally question the
effectiveness of publishing prices because calculated health care costs
are complex and unique to each patient.72
In health care markets, consumers often have difficulty finding
useful price information for hospital stays, operations, or prescription
drugs.73 Because hospitals charge significantly different prices, some
argue that price transparency would cause the health care market to be
more efficient.74 Conversely, others claim the health care market is

67.

Frakt & Mehrotra, supra note 27, at 561.

68.

Ubel, supra note 59.

69.

Arlene Weintraub, Will President Trump’s Hospital Price Transparency
Plan Lower Costs?, FORBES (Jul. 2, 2019, 10:33 AM),
https://www.forbes.com/sites/nextavenue/2019/07/02/will-presidenttrumps-hospital-price-transparency-plan-lower-costs/#4131957d114e
[https://perma.cc/3CH6-AMGX].

70.

Id.

71.

Id.

72.

See E. John Steren & Patricia M. Wagner, Will Price Transparency
Benefit Consumers or Facilitate Antitrust Violations?, NAT’L L. REV.
(Oct. 31, 2019), https://www.natlawreview.com/article/will-pricetransparency-benefit-consumers-or-facilitate-antitrust-violations
[https://perma.cc/ED5K-CH39]; Reed Abelson & Margot Sanger-Katz, A
New Trump Order May Make More Health Care Prices Public, N.Y.
TIMES
(June
24,
2019),
https://www.nytimes.com/
2019/06/24/upshot/health-care-price-transparency-trump.html
[https://perma.cc/6T27-RUKN].

73.

See AUSTIN & GRAVELLE, supra note 19.

74.

Id. at CR-33.
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unique and cannot be compared to markets for “shoppable” goods.75
Critics claim health care price transparency tools are ineffective and
may instead contribute to rising health care costs.76 Despite opposition
to health care price transparency tools, research suggests that the tools,
combined with consumers’ financial incentives to compare prices, may
produce desired market competition and lower health care costs.77
Therefore, price transparency provides more benefits than harm to
consumers and patients, supporting the federal and state governments’
actions to increase health care price transparency.

II. Federal Efforts: Price Transparency Final Rules
The American federal government asserts that increased healthcare
price transparency enables consumers to make fully-informed health
care decisions.78 On June 24, 2019, President Trump signed the
“Executive Order Improving Price and Quality Transparency in
American Healthcare to Put Patients First.”79 The executive order
instructs the Department of Health and Human Services (HHS) to
develop a policy and draft new rules80 to ensure that patients possess
basic information to actively select their preferred or necessary health
care.81 The order also discusses the need to incentivize consumers to
search for and evaluate health care cost information to compare
“shoppable” services’ prices.82 Because many consumers do not know
what their out-of-pocket expenses will be until they receive notice from
their insurance company explaining hospital charges, the federal
government seeks to investigate methods to make negotiated discounts
and patients’ costs more available.83 This is important to patients since
75.

Weintraub, supra note 69.

76.

Tamara Keith & Selena Simmons-Duffin, Trump Administration Pushes
To Make Health Care Pricing More Transparent, NPR (June 24, 2019
1:22
PM),
https://www.npr.org/sections/health-shots/2019/06/24/
735432387/trump-administration-pushes-to-make-health-care-pricingmore-transparent [https://perma.cc/NS9X-4X92].

77.

See Whaley et al., supra note 42.

78.

See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,849 (June 24, 2019).

79.

Id.

80.

Katie Keith, Unpacking The Executive Order On Health Care Price
Transparency And Quality, HEALTHAFFAIRS (June 25, 2019),
https://www.healthaffairs.org/do/10.1377/hblog20190625.974595/full/
[https://perma.cc/N4LL-8V97].

81.

See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,850 (June 24, 2019).

82.

“‘[S]hoppable’ services (common services offered by multiple providers
through the market, which patients can research and compare before
making informed choices based on price and quality).” Id. at 30,849.

83.

Id.
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they typically do not have concerns about list prices but rather about
their out-of-pocket costs after insurance coverage.84 Marni Jameson
Carey, executive director of the Association of Independent Doctors,
responded to the executive order stating, “[r]eal price transparency is
the first, and single most important step toward fixing America’s
broken, over-priced health-care system.”85 The federal government aims
to eliminate unnecessary barriers to price transparency and increase the
availability of meaningful price information for patients to boost their
control over their health care resources.86
A.

Inpatient Prospective Payment System Final Rule

On January 1, 2019, the Centers for Medicare and Medicaid’s Fiscal
Year 2019 Inpatient Prospective Payment System (IPPS) final rule
became effective.87 The price transparency part of the IPPS final rule
requires hospitals to publish and annually update “machine readable”
chargemasters, or lists of hospitals’ standard charges for individual
items and services.88 Standard charges are the prices hospitals set for a
provided service or item before negotiating any discounts or billing
payers and patients.89 Some hospitals clearly publish their charges on
their websites while others post incomprehensible price data.90
CMS requires hospitals to publish hospital price data, and most
hospitals mention this on their chargemaster webpages.91 Hospitals also
warn that the charges do not represent a patient’s out-of-pocket costs
84.

Keith, supra note 80.

85.

Healthcare Industry Experts Praise White House Executive Order On
Healthcare Price Transparency, PATIENTS RTS. ADVOC. (June 24, 2019),
https://www.patientrightsadvocate.org/healthcare-industry-expertspraise-white-house-executive-order-on-healthcare-price-transparency
[https://perma.cc/5Q7C-STV5].

86.

See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,850 (June 24, 2019).

87.

Wynne et al., supra note 12.

88.

83 Fed. Reg. 41,144, 41,686 (Aug. 17, 2018).

89.

ASS’N OF AM. MED. CS., PRICE TRANSPARENCY: COMMON DEFINITIONS,
https://www.aamc.org/system/files/c/2/450000-pricetran_
commondefs.pdf [https://perma.cc/2QUA-8GU4].

90.

Harris Meyer, Hospitals Vary in Publishing CMS Chargemaster
Prices, MOD.
HEALTHCARE (Jan.
7,
2019,
12:00
AM),
https://www.modernhealthcare.com/article/20190107/TRANSFORMA
TION04/190109931/hospitals-vary-in-publishing-cms-chargemasterprices [https://perma.cc/W24N-77HQ].

91.

See Chargemaster, NW. MED., https://www.nm.org/patients-and-visitors
/billing-and-insurance/chargemaster [https://perma.cc/W7G4-7LQG];
Price Transparency Disclosure, MEDSTAR GEORGETOWN UNIV. HOSP.,
https://www.medstargeorgetown.org/for-patients/patients-and-visitors/
billing-and-insurance/hospital-charge-description-master/
[https://perma.cc/FDR3-JMD].
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but rather the amount the hospital would charge an insurer.92
Therefore, patients should talk to their insurance providers to know
how much they would be expected to pay, in other words, their out-ofpocket costs.93 Typically the chargemasters consist of thousands of rows
listing services, medications, and surgical supplies along with the
respective prices.94 The data set is overwhelming and difficult for a
layperson to understand.95 For example, one may find “Glucose Body
Fluid” for $90 or “2.4 Pins” for $105, but what does that mean?96 If
patients wanted to look through the pricing spreadsheets with the hope
of determining approximately how much a hip replacement would cost,
they would likely struggle to calculate a cost estimate because the
patients likely would not be able to identify all the necessary
medications or supplies to add up a cost estimate for the service. Even
if they figured out what to add together, they would not know the
applicable out-of-pocket cost because hospitals list standard charges.97
Critics argue that the IPPS final rule requirements are useless and
misleading for consumers because the hospitals’ price data are not
personalized cost estimates.98 Out-of-pocket prices depend on an
individual’s health plan benefits and deductible status.99 Therefore,
posting chargemasters would not achieve the goal of driving down
health care costs because they are not the most effective way to change
consumers’ behaviors in the health care market.100 Conversely, HHS
Secretary, Alex Azar, and CMS Administrator, Seema Verma, claim
that these requirements foster price transparency for medical services,
prescription drugs, and health plans.101 They believe the published
hospital chargemasters are stepping stones to address rising healthcare
costs and inform patients about the cost in healthcare.102
Azar and Verma make valid claims with their beliefs that hospital
chargemasters improve healthcare price transparency for patients.
While the IPPS Final Rule requires hospitals to provide patients access
92.

NW. MED., supra note 91.

93.

Id.

94.

See Id. (cited material is available through selecting links).

95.

Reinhardt, supra note 20.

96.

See Northwestern Memorial Hospital Standard Charges, NW. MED.,
https://www.nm.org/-/media/northwestern/resources/patients-andvisitors/billing-and-insurance/northwestern-medicine-northwesternmemorial-hospital-standard-charges.txt [https://perma.cc/W7G4-7LQG].

97.

See Reinhardt, supra note 20, at 1642-43.

98.

Meyer, supra note 90.

99.

Id.

100. Id.
101. Id.
102. Id.
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to review costs, the chargemasters do not offer understandable or
relevant prices for the patients. Therefore, the IPPS Final Rule would
likely be ineffective to expand health care price transparency in a way
that helps patients to know costs before treatment or make their own
decisions that may affect the health care market and its prices.
B.

Outpatient Prospective Payment System Final Rule

On November 15, 2019, CMS finalized the Outpatient Prospective
Payment System (OPPS) final rule.103 The OPPS final rule expanded
on the IPPS final rule by providing hospitals with more specific
guidance for publishing price information online.104 The rule’s goal is to
continue promoting health care price transparency with publicly
accessible hospital standard charges.105 Starting on January 1, 2021,
hospitals are required to continue posting a consumer-friendly,
comprehensive, machine-readable file for all their charges and post at
least 300 shoppable services such as magnetic resonance imaging (MRI)
scans and x-rays.106 Failure to do so may result in a fine of $300 per
day.107 The Department of HHS and CMS believe that hospitals’
compliance with these requirements will allow patients to make more
informed health care decisions.108 Likewise, if patients are more aware
of various hospitals’ charges, then the chargemasters may achieve the
ultimate goals of increasing market competition and lowering costs.109
Compared to the IPPS final rule, the possible fines charged to hospitals
for failing to publish price information online may result in compliance
and action from the hospitals. However, the IPPS and OPPS final rules

103. CTRS. FOR MEDICARE & MEDICAID SERVS., CY 2020 HOSPITAL
OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) POLICY CHANGES:
HOSPITAL PRICE TRANSPARENCY REQUIREMENTS (CMS-1717-F2) (Nov.
15, 2019), https://www.cms.gov/newsroom/fact-sheets/cy-2020-hospitaloutpatient-prospective-payment-system-opps-policy-changes-hospitalprice
[hereinafter
HOSPITAL
OPPS
POLICY
CHANGES]
[https://perma.cc/7F3W-S2LJ].
104. Id.
105. DEP’T OF HEALTH AND HUMAN SERVICES, MEDICARE AND MEDICAID
PROGRAMS: CY 2020 HOSPITAL OUTPATIENT PPS POLICY CHANGES AND
PAYMENT RATES AND AMBULATORY SURGICAL CENTER PAYMENT SYSTEM
POLICY CHANGES AND PAYMENT RATES. PRICE TRANSPARENCY
REQUIREMENTS FOR HOSPITALS TO MAKE STANDARD CHARGES PUBLIC
(Nov. 7, 2019), https://www.hhs.gov/sites/default/files/cms-1717-f2.pdf
[hereinafter Medicare and Medicaid]; See also U.S. DEP’T HEALTH & HUM.
SERVS. Medicare and Medicaid Programs Rule, 45 C.F.R. pt. 180 (2021).
106. CTRS.

FOR

MEDICARE & MEDICAID SERVS., supra note 103.

107. Medicare and Medicaid, supra note 105.
108. Id.
109. Id.
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bring forward debatable concerns about the effectiveness of the rules
for patients to look up health care costs.
C.

Responses to the IPPS and OPPS Final Rules

When the OPPS final rule was open for public comment, hospitals
and insurers reacted to the proposal.110 They claimed that the vast
amounts of public price data online will overwhelm consumers instead
of helping them better understand health care costs.111 Furthermore,
hospitals and insurers argued that compliance with the rule would
require disclosure of trade secrets, encumber price negotiations between
providers and payers, and adversely raise prices.112 Larry Levitt,
Executive Vice President of the Kaiser Family Foundation, mentioned
that the penalty for the transparency rule is weak, and hospitals would
likely rather pay $300 a day than publish massive amounts of data on
negotiated prices in addition to updating the data annually.113 Hospitals
have a greater incentive to protect what they consider proprietary
information.114
Additionally, since CMS issued the OPPS final rule, hospitals have
been concerned that the availability of chargemaster information will
only hinder consumers from accessing appropriate health care.115
Hospitals claim that patients may be overwhelmed and confused by the
data and hinder patients from seeking appropriate medical care.116
Shortly after the rule’s release, four hospital organizations sued HHS
for violating the First Amendment, challenging HHS’s statutory
authority to require public disclosure of negotiated retail prices between
insurers and hospitals.117
110. Selena Simmons-Duffin, Trump Wants Insurers and Hospitals To Show
Real Prices To Patients, NPR (Nov. 15, 2019, 1:23 PM ET),
https://www.npr.org/sections/health-shots/2019/11/15/779707609/
trump-wants-insurers-and-hospitals-to-show-real-prices-to-patients
[https://perma.cc/SG89-ZPUP].
111. Julie Appleby, White House Unveils Finalized Health Care Price
Transparency Rule, KAISER HEALTH NEWS, (Nov. 15, 2019),
https://khn.org/news/white-house-unveils-finalized-health-care-pricetransparency-rule/ [https://perma.cc/4JCE-ZEK5].
112. Id.
113. Simmons-Duffin, supra note 110.
114. Peggy Keene, Hospitals Have Trade Secrets Too, KLEMCHUK LLP (Nov.
3, 2020), https://www.klemchuk.com/ip-law-trends/healthcare-claimspricing-as-trade-secret-as-government-calls-for-transparency
[https://perma.cc/FWC7-9E88].
115. Wynne et al., supra note 12.
116. Id.
117. Ayla Ellison, Hospital Groups Sue HHS to Block Price Transparency
BECKER’S
HOSP.
REV.
(Dec.
4,
2019),
Rule,
https://www.beckershospitalreview.com/legal-regulatory-issues/hospitalgroups-sue-hhs-to-block-price-transparency-rule.html
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Rick Pollack, President and CEO of the American Hospital
Association, commented, “[i]nstead of giving patients relevant
information about costs, this rule will lead to widespread confusion and
even more consolidation in the commercial health insurance industry.
We stand ready to work with CMS and other stakeholders to advance
real solutions for patients.”118 Pollack is concerned that patients will not
use the chargemasters. Instead, the available data may incentivize
health insurance companies to merge since the mandated price
disclosure interferes with the price negotiations between hospitals and
insurance companies.119 Merging would allow health insurers to gain
market power in an already heavily concentrated market and influence
prices.120
On June 23, 2020, the United States District Court for the District
of Columbia granted HHS’s Motion for Summary Judgment against the
hospital associations.121 Judge Nichols found that the OPPS final rule
was legal to require disclosure of hospital charges and the hospitals were
trying to limit patients’ access to medical prices.122 The hospital
associations immediately appealed to overturn the upholding of the
OPPS final rule.123 On December 29, 2020, the United States Court of
Appeals for the District of Columbia Circuit affirmed the District

[https://perma.cc/ZNT9-UNXD]; Reed Abelson, Hospitals Sue Trump to
Keep Negotiated Prices Secret, N.Y. TIMES (Dec. 4, 2019),
https://www.nytimes.com/2019/12/04/health/hospitals-trump-pricestransparency.html [https://perma.cc/EG35-UZVH].
118. Ellison, supra note 117.
119. John Commins, Price Transparency Is Coming. How Will You Prepare?,
HEALTHLEADERS (Oct. 23, 2019), https://www.healthleadersmedia.com/
strategy/price-transparency-coming-how-will-you-prepare
[https://perma.cc/XE4P-22XR].
120. Id.
121. Am. Hosp. Assoc. v. Azar, 468 F.Supp.3d 372, 372-73 (D.D.C. June 23,
2020).
122. Id. See also Thomas Sullivan, District Court Upholds Hospital Price
(June
28,
2020),
Transparency
Rule,
POLICYMED
https://www.policymed.com/2020/07/district-court-upholds-hospitalprice-transparency-rule.html [https://perma.cc/39FW-QAKT]; Ayla
Ellison, Hospitals Lose Lawsuit Against HHS Over Price Disclosure Rule,
BECKER’S
HOSP.
REV.
(June
23,
2020),
https://www.beckershospitalreview.com/finance/hospitals-lose-lawsuitagainst-hhs-over-price-disclosure-rule.html
[https://perma.cc/57WRRSWV].
123. Notice of Appeal on Court Decision on Public Disclosure of Negotiated
Rates June 23, 2020, AM. HOSPITAL ASS’N, (June 24, 2020),
https://www.aha.org/legal-documents/2020-06-24-notice-appeal-courtdecision-public-disclosure-negotiated-rates-june-23
[https://perma.cc/8D9H-PSYA].
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Court’s rejection of hospitals’ challenge to the rule.124 Thus, hospitals
must prepare to disclose pricing information as CMS announced plans
to start auditing hospitals and enforcing compliance in January 2021.125
D.

Transparency in Coverage Final Rule

On October 29, 2020, CMS finalized the Transparency in Coverage
final rule.126 Unlike the previous final rules that focus on hospitals, this
final rule requires certain group health plans and health insurance
issuers to disclose patient pricing information.127 The final rule requires
payers to make the information available through an online, self-service
tool or paper form if requested.128 The rule’s purpose is to provide
patients with estimates and an understanding of their out-of-pocket
expenses so that the patients may efficiently shop for medical items and
services.129 The Transparency in Coverage final rule also requires plans
and issuers to disclose negotiated rates of in-network providers,
historical, allowed out-of-network amounts, and drug pricing
information on an internet website.130 The Transparency in Coverage
final rule aims to reduce secrecy behind health care costs and increase
competition within the private health care industry. 131
Although the Transparency in Coverage final rule has only recently
been published, criticism has already come to light. America’s Health
Insurance Plans (AHIP) came forward with claims arguing that
publishing privately negotiated rates would reduce incentives to offer
lower rates during future negotiations, which would raise premium
prices.132 On the other hand, consumer advocates applaud the new final
rule as a significant step to increase price transparency, supporting
consumers to make more price-conscious decisions and prevent

124. See AHA, 2020 WL 7703008.
125. CTRS. FOR MEDICARE & MEDICAID SERVS., MONITORING FOR HOSPITAL
PRICE TRANSPARENCY (2020), https://www.cms.gov/outreachand
educationoutreachffsprovpartprogprovider-partnership-email-archive/
2020-12-18-mlnc-se [https://perma.cc/6KU8-CD38].
126. CTRS. FOR MEDICARE & MEDICAID SERVS., CMS-9915-F, TRANSPARENCY
IN COVERAGE FINAL RULE FACT SHEET (2020).
127. Kelsey Wadill, CMS Finalizes Price Transparency Rule with Self-Service
PAYER
INTEL.
(Oct.
29,
2020),
Tool,
HEALTH
https://healthpayerintelligence.com/news/cms-finalizes-pricetransparency-rule-with-self-service-tool [https://perma.cc/Z752-FUE2].
128. 85 Fed. Reg. 72,158, 72,158 (Nov. 12, 2020).
129. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 126.
130. Id.
131. Id.
132. Nelson, supra note 14.
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uninformed or excessive price increases.133 The responses received thus
far regarding the Transparency in Coverage final rule reflect the key
arguments in the debate about price transparency as anticipated and
discussed in Section II. The Transparency in Coverage final rule
requires action starting at various points between 2022 and 2024.134

III. State Efforts for Price Transparency
As health care costs continue to increase, states have been
prioritizing the passage of new laws concerning health care prices.135
One area of focus has been improving price transparency.136 Eighteen
states created laws to establish all-payer claims databases (APCDs),
which collect health care price and quality information.137 Eight states
have websites that make price and quality information available to the
public.138 APCDs usually post providers’ list prices, the total amounts
a provider expects to be paid for the health care services, instead of the
out-of-pocket amounts.139 The more effective APCDs allow consumers
to go on a website to view and compare provider- and plan-specific price
estimates.140

133. Joe Records & Michelle Chipetine, HHS Finalizes Health Plan Price
Transparency
Rule,
C&M HEALTH L.
(Nov.
23,
2020),
https://www.cmhealthlaw.com/2020/11/hhs-finalizes-health-plan-pricetransparency-rule/ [https://perma.cc/VF7W-PKHC].
134. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 126.
135. MURRAY, supra note 13.
136. Id.
137. All-Payer Claims Databases, AGENCY FOR HEALTHCARE RES. AND
QUALITY,
https://www.ahrq.gov/data/apcd/index.html
[https://perma.cc/4UAF-8MEP].
138. Murray et al., supra note 13.
139. Erin C. Fuse Brown & Jaime S. King, ERISA as a Barrier for State
Health Care Transparency Efforts, in TRANSPARENCY IN HEALTH AND
HEALTH CARE IN THE UNITED STATES: LAW AND ETHICS 301, 302 (2019).
140. Id. at 302–03.
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141

A.

All-Payer Claims Databases (APCDs)

Many states established APCDs to provide transparent information
for patients to compare prices.142 APCDs combine data from all payers
in a state and give state policymakers information on costs, quality,
utilization patterns, access and barriers to care, and other health care
measures.143 The National Association of Health Data Organizations
(NAHDO) and the Regional All Payer Healthcare Information Council
(RAPHIC) define APCDs as “databases, created by state mandate,
that typically include data derived from medical claims, pharmacy
claims, eligibility files, provider files, and dental claims from private
and public payers. In states without a legislative mandate, there may
be voluntary reporting of these data.”144 States are voluntarily and
legally mandating APCDs as sources for transparency to reform health
care activities.145 States use APCDs to evaluate health care costs and
provide state stakeholders with information about health care

141. The APCD Council’s website presents a visual map of states and their
status regarding APCDs. Interactive State Report Map, ALL-PAYER
CLAIMS DATABASE COUNCIL, https://www.apcdcouncil.org/state/map
[https://perma.cc/AEY9-V6F3].
142. Denise Love et al., All-Payer Claims Databases: State Initiatives to
Improve Health Care Transparency, 99 THE COMMONWEALTH FUND 1
(Sept.
2010),
https://www.commonwealthfund.org/sites/default/
files/documents/___media_files_publications_issue_brief_2010_sep_
1439_love_allpayer_claims_databases_ib_v2.pdf
[https://perma.cc/SKS9-EWJY].
143. Id. at 2, 4.
144. Id. at 2.
145. Id.
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utilization patterns, in addition to identifying state needs.146 Overall,
APCDs allow states to have a foundation to evaluate reform efforts and
understand the health care provided to their citizens.147
More states are implementing APCDs by law each year.148 There
are altogether over 30 states maintaining, developing, or showing strong
interest in establishing an APCD.149 States with websites use APCD
data to present cost information to consumers.150 As APCDs combine
data from all state payers and make them publicly available, consumers
have tools to compare prices to make health care decisions.151
An individual can access Maine’s APCD on the CompareMaine
website to find the cost of a procedure.152 On CompareMaine, a patient
can select or search for a particular procedure and view its average cost
along with a list of facilities that provide the procedure in Maine and
their prices.153 The patient can narrow down the results by restricting
the location radius or sorting priorities such as the average total cost
from low to high or high to low.154 Other sorting categories are the
hospitals’ ratings concerning patient experience or the prevention of
serious complications.155 Regarding cost breakdown, CompareMaine
shows how a price is split between the facility and professional service
costs, meaning the amounts the hospitals and the service-providers
charge for the procedure.156 Maine’s APCD also provides the estimated
number of times the facility performs the procedure.157 APCDs are
generally more consumer-friendly than chargemasters because the
146. Id.
147. Jo Porter et al., The Basics of All-Payer Claims Databases, 2014 ROBERT
WOOD JOHNSON FOUND.: STATE HEALTH AND VALUE STRATEGIES 7 (2014).
148. Id. at 1.
149. AGENCY FOR HEALTHCARE RES. AND QUALITY, supra note 137.
150. Id.
See N.H.
COMPREHENSIVE
HEALTH
CARE
INFO.
SYS.,
https://nhchis.com/ [https://perma.cc/JR5Y-9RFZ]; Compare the Costs
& Quality of HealthCare Procedures in Maine, COMPARE ME.,
https://www.comparemaine.org [https://perma.cc/T5L2-DMPZ]; see
also Health Information and Analysis, CTR. FOR HEALTH INFO. AND
ANALYSIS,
https://www.chiamass.gov/our-data/
[https://perma.cc/C3SE-4KRZ].
151. Love et al., supra note 142.
152. See COMPARE ME., supra note 150.
153. Id.;
see,
e.g.,
Electrocardiogram,
COMPARE
https://www.comparemaine.org/?page=report&procedure=93005
[https://perma.cc/3BMD-67HJ].

ME.,

154. COMPARE ME., supra note 150; see, e.g., COMPARE ME., supra note 153.
155. COMPARE ME., supra note 150; see, e.g., COMPARE ME., supra note 153.
156. COMPARE ME., supra note 150; see, e.g., COMPARE ME., supra note 153.
157. COMPARE ME., supra note 150; see, e.g., COMPARE ME., supra note 153.
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APCD websites are easier to navigate as they are reminiscent of typical
online shopping. However, patients still lack out-of-pocket cost
estimates, which matter most to patients.
APCDs improve price transparency in the sense that patients may
have a better, general idea of the charge for a medical service before its
occurrence. APCDs can be valuable as they allow access to data for
healthcare stakeholders seeking information for research, policymaking,
and purchasing activities, but as with other vast data sets, there are
concerns regarding APCDs.158
B.

Shortcomings of APCDs

The major shortcoming of APCDs is that consumers will not know
their estimated out-of-pocket costs or deductible status after scanning
a state’s APCD website.159 One study evaluated how to improve state
health care price transparency websites.160 The researchers asserted that
APCDs may be more relevant and effective for patients if the published
prices are for predictable, non-urgent services, rather than
unpredictable, emergent services like surgeries or hospitalizations for
life-threatening conditions.161 This is likely because patients would not
have time or anticipate to use an APCD to analyze prices for emergency
medical treatment compared to a scheduled service. Moreover, states
may improve price transparency if the APCDs report cost estimates for
full episodes of care.162 Specifically, patients may view one cost estimate
with a breakdown of the aggregated prices, including all facility,
professional, and other fees.163 These added factors improve health care
price transparency.164
The majority of states have legally mandated or voluntarily
established APCDs to offer their citizens tools to make health care
prices more transparent.165 Although some states post list prices that
are not useful to consumers who are more concerned about out-ofpocket expenses, well-implemented APCDs provide specific cost

158. ANTHEM PUB. POL’Y INST., ACHIEVING STATES’ GOALS FOR ALL-PAYER
CLAIMS
Databases
(June
2018),
https://www.antheminc.com/
cs/groups/wellpoint/documents/wlp_assets/d19n/mzq1/~edisp/pw_g34
5393.pdf [https://perma.cc/P7SA-46L4].
159. Stephen Barlas, Health Care Price Transparency Initiatives Are All the
Rage, 43 PHARMACY & THERAPEUTICS 744, 746 (2018).
160. See Jeffrey T. Kullgren et al., A Census of State Health Care Price
Transparency Websites, 309 JAMA 2437, 2437 (2013).
161. Id.
162. Id.
163. Id. at 2437–38.
164. Id. at 2438.
165. AGENCY FOR HEALTHCARE RES. AND QUALITY, supra note 137.
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estimates based on patients’ providers and insurance plans.166 APCDs
improve price transparency in the sense that patients may have a better
idea of how much they are expected to pay for a medical service prior
to its occurrence. But, there is debate as to whether the APCDs’
published price data enable patients to make independent health care
decisions, ultimately increasing market competition and decreasing
costs.

IV. Recommendation: Health Care Clearinghouses
The federal and state governments are attempting to combat rising
health care costs with price transparency. However, the APCDs and
requirements to publish hospitals’ prices have been minimally helpful
for consumers and highly opposed by hospitals and insurers.167 Although
the OPPS final rule will impose stricter requirements, the published
prices would not be consumer-specific but rather standard charges.168
For health care consumers to receive a valuable cost estimate, the
necessary elements to consider are: (1) the specific diagnosis and
treatment for which they will be billed; (2) the contracted rate between
their insurer and provider; and (3) where on the spectrum of deductibles
and out-of-pocket maximums they will be when provided service. Then,
a consumer may calculate a more accurate cost estimate by combining
the provider’s price with the consumer’s current insurance status.169
This Note proposes to create a process involving medical claims
clearinghouses that would produce specific cost estimates for consumers
seeking prices for non-emergent medical expenses.
A.

Current Health Care Clearinghouse Process

A clearinghouse is a third-party that interprets data, acting as a
middleman between the provider and the payer.170 A health care
clearinghouse is defined as a public or private entity that changes health
information from a nonstandard format to standard data elements to
produce cost estimates.171 Clearinghouses are covered entities under the
166. Brown & King, supra note 139, at 302–03.
167. See supra Sections III and IV.
168. See supra Section III.D.
169. See U.S. GOV’T ACCOUNTABILITY OFF., GAO-11-791, HEALTH CARE PRICE
TRANSPARENCY: MEANINGFUL PRICE INFORMATION IS DIFFICULT FOR
CONSUMERS TO OBTAIN PRIOR TO RECEIVING CARE 8 (2011).
170. What is a Healthcare Clearinghouse & Why Use One?, NEARTERM (Aug.
21, 2018), https://nearterm.com/what-is-a-healthcare-clearinghousemedical-billing-electronic-claims/ [https://perma.cc/EJ98-QEVZ].
171. “Health care clearinghouse means a public or private entity, including a
billing service, repricing company, community health management
information system or community health information system, and ‘valueadded’ networks and switches, that does either of the following functions:
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Health Insurance Portability and Accountability Act (HIPAA) and
subject to strict standards.172 Therefore, the transmissions of medical
claims between providers, clearinghouses, and payers are secure patient
health information.173 Generally, a clearinghouse takes electronic
medical claims’ information, strips the data to create an estimate, and
then submits information electronically to the contracted insurance
company.174 When clearinghouses “strip” or “scrub” the claim to
translate the data from nonstandard to standard elements,
clearinghouses check the claim for errors and verify the data is
compatible with the payer software to produce the costs.175 The
clearinghouse also ensures that the procedural and diagnosis codes are
valid and that each procedure code is appropriate for the diagnosis code
submitted with it.176
The typical clearinghouse process starts when a patient visits the
doctor, who then diagnoses the patient and provides the treatment.177
The provider’s administrators then send the medical claim to the
patient’s medical billing clearinghouse account.178 The medical
clearinghouses have contracts with and are trained by insurance
(1) Processes or facilitates the processing of health information received
from another entity in a nonstandard format or containing nonstandard
data content into standard data elements or a standard transaction. (2)
Receives a standard transaction from another entity and processes or
facilitates the processing of health information into nonstandard format
or nonstandard data content for the receiving entity.” 45 C.F.R. 160.103
(2018).
172. See Summary of HIPAA Privacy Rule, U.S. DEP’T OF HEALTH & HUM.
SERV.
(2003),
https://www.hhs.gov/hipaa/for-professionals/
privacy/laws-regulations/index.html [https://perma.cc/GM4E-HASP].
173. Medical Billing Clearinghouse: What is the Role of a Medical
Clearinghouse?, APEX EDI, https://info.apexedi.com/what-is-the-role-ofa-medical-clearinghouse? [https://perma.cc/G6F3-HTEP].
174. Suzanne Prasad, Choosing the Best Medical Billing Clearinghouse for
Your
Practice, REVENUEXL
(Nov.
11,
2020),
https://www.revenuexl.com/blog/healthcare-clearinghouse-medical
[https://perma.cc/2R3R-QXNA]; J.M. Sculley, What is a Clearinghouse
for Medical Claims, and What Do They Do?, CLEARINGHOUSES.ORG,
https://coa.org/docs/WhitePapers/Clearinghouses.pdf
[https://perma.cc/D6JN-HTJ9].
175. Id.
176. Id.
177. Harold Gibson, 6 Key Steps of a Successful Medical Billing Process, MSCRIBE MEDICAL BILLING (Jan. 23, 2015), https://www.m-scribe.com/
blog/6-signs-you-have-a-great-medical-billing-process
[https://perma.cc/D3EY-L7RN].
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Guide
to
Medical
Billing
Clearinghouses,
MB-GUIDE,
http://www.mb-guide.org/medical-billing-clearinghouses.html
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companies.179 The clearinghouses have the patient’s information for the
particular claim, such as medical history, insurance plan, and insurance
status, from the insurance companies.180 After receiving a medical claim,
the clearinghouse scrubs or checks the claim for errors and translates
the claim to a “standard data form,” which is a special data coding
language to calculate a cost. When the claim passes inspection, the
clearinghouse produces a cost breakdown and securely sends the
electronic claim to the appropriate payer, such as a private health
insurance company.181 At this point, the payer typically accepts or
denies the claim.182 The payer receives the cost breakdown and pays its
portion.183 Then, the provider charges the patient for the rest of the
claim, or the out-of-pocket cost.184

Clearinghouses: Current General Process
Patient visits the doctor, who diagnoses
Patient and orders a procedure.
Provider

Payer receives
breakdown of costs.
Payer

Provider's administration sends the
claim to the patient's medical
clearinghouse.

The clearinghouse scrubs the claim and
produces a cost. The revised claim is
securely sent to the distinguished payer.
Clearinghouse

B.

Proposal: Clearinghouses for Cost Estimation

For non-emergent health care, clearinghouses can be useful entities
to provide patients with individualized, specific cost estimates and
improve price transparency. Clearinghouses can consider the nature of
179. See Paul G. Hackett, Medical Billing Clearing House, BALANCE SMALL
BUS.,
https://www.thebalancesmb.com/medical-billing-clearinghouse1794650 [https://perma.cc/DL8F-L5HS].
180. See id.
181. Prasad, supra note 174; Sculley, supra note 174.
182. What is a Clearinghouse for Medical Claims, and What Do They Do?,
https://coa.org/docs/WhitePapers/
CLEARINGHOUSES.ORG,
Clearinghouses.pdf [https://perma.cc/C39A-NNUT].
183. 6 Key Steps of a Successful Medical Billing Process, M-SCRIBE MED.
BILLING (Jan. 13, 2015), https://www.m-scribe.com/blog/6-signs-youhave-a-great-medical-billing-process [https://perma.cc/D3EY-L7RN].
184. Id.
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a patient’s claim based on submitted information to determine how
much the insurer and patient will pay respectively. I propose that
clearinghouses be involved in a process before a patient receives a
medical service. My proposal also includes aggregators that are
currently not a part of any medical billing process but would be
separately contracted with hospitals. The process is most functional and
efficient with both aggregators and clearinghouses because hospitals
would pay and contract with aggregators. Meanwhile, insurance
companies pay and contract with clearinghouses. As will be further
discussed in this section, aggregators and clearinghouses have different
functions and access to information based on their contracted
relationships. However, together, aggregators and clearinghouses have
the potential to create an efficient and helpful cost estimation process
to improve health care price transparency. The cost estimate process I
propose does not apply to emergency health care situations because
there would not be enough time to receive cost estimates as doctors
make quick decisions.
First, a patient will visit the doctor who will order a future
procedure. A patient may go online to an aggregator’s website. Because
an aggregator is separately contracted with hospitals, the patient will
not have to pay anything to the aggregator because it receives
commissions from the hospitals. On the aggregator’s website, the
patient may submit a request for proposal (RFP). This would require
the patient to answer several questions concerning the specific
procedure or service, location, hospital preferences, and insurance plan,
which includes the specific clearinghouse contracted with an
individual’s insurer. The aggregator will attain bids or determine list
prices from hospitals within the RFP specifications. The aggregator
then sends all the information to the clearinghouse.
The clearinghouse can apply the patient’s information and
insurance plan to the hospitals’ prices and break down the costs to what
the insurance company would cover and what would be the patient’s
out-of-pocket costs. The clearinghouse sends the cost estimates back to
the aggregator. Finally, the aggregator forwards the patient a list of
hospitals and bundled out-of-pocket cost estimates for the ordered
procedure based on the patient’s insurance plan and status. The cost
estimates are bundled as each estimate includes all service, equipment,
and medication fees. This cost estimate process with a health care
clearinghouse allows patients to have a better, personalized idea of what
they will pay after receiving the medical treatment. Patients may also
decide to receive a second opinion from another provider.
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Proposal: Clearinghouses for Cost Estimates
Patient
XYZ Insurance

1. Patient visits the
doctor who orders a
future procedure.

Provider

2. Patient submits
a request for
proposal (RFP).

H2: $30K
H1: $10K

C.

H3: $15K

3. Aggregator forwards to
Clearinghouse all
information. Clearinghouse
applies Patient A’s insurance Clearinghouse
to hospitals’ prices.

4. Clearinghouse
sends Aggregator
cost estimates, then
Aggregator provides
Patient a list of
hospitals and their
bundled, out-ofpocket cost
estimates based on
A’s insurance plan
and status.

Advantages of Clearinghouses

Clearinghouses have several advantages that contribute to health
care price transparency. First, clearinghouses will provide patients with
personal cost estimates based on their insurance information.
Clearinghouses can also bundle all the medical claims together so that
patients receive one cost estimate for the medical procedure and all
other drugs or hospital charges instead of processing them separately.
Secondly, clearinghouses will create a more efficient cost estimation
process as they simplify and speed up the process for consumers.
Patients will not have to find complicated pricing data published online.
In fact, patients will not have to do much work besides inputting data
based on personal preferences and insurance information. Since the
process is done electronically using expert software systems,
clearinghouses can produce estimates and send them in a short amount
of time.
Also, clearinghouses are third parties that will protect the patients’
information and provide unbiased cost estimates because clearinghouses
are middlemen between the providers and payers that are legally bound
by HIPAA. Broadly considered, clearinghouses may reduce errors and
expose hidden costs charged by providers due to improved price
transparency between all parties.185 Involving clearinghouses offers
significant improvements to health care price transparency for patients,
but difficult challenges remain.
D.

Concerns of Clearinghouses

While a health care cost estimation process involving clearinghouses
will improve price transparency, important questions remain about cost
coverage and whether the price transparency will ultimately lower
health care costs. Insurance companies pay for clearinghouse services in

185. See Best Practices in Patient Cost Estimation, MICROMD (Dec. 11, 2018),
https://www.micromd.com/enotes/best-practices-in-patient-costestimation/; Prasad, supra note 174.
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the current medical billing process involving clearinghouses.186 Insurers
should continue to contract with and pay for clearinghouses. An
implementation of a new cost estimation feature in the medical billing
process will already create necessary adjustments, so the insurance
companies remaining as contractors and payers for medical
clearinghouses’ services will minimize the complexity of the new cost
estimation process.
Another concern is whether the clearinghouses would estimate costs
for all types of providers and services. Clearinghouses typically work
with all types of providers including large hospitals and private doctors’
offices.187 Because clearinghouses already handle all types of medical
claims for services such as surgical procedures or therapy, both in and
out of an insurance company’s network, clearinghouses should be able
to provide cost estimates for a vast range of providers and services.
The ultimate question is whether the cost estimation process
performed by clearinghouses will promote price transparency for
patients and produce the desired reduction in health care costs. If
insurers continue to cover the clearinghouses’ services, patients will
likely pay more for their insurance since clearinghouses will provide
additional services for cost estimation. A major concern is whether
insurance companies may force patients to select the cheapest provider
because the insurance company is paying for the clearinghouse’s
services. Although this is a valid concern, it should not be a substantial
issue. Based on how insurance companies and providers interact today,
insurance companies already know the various prices charged as they
negotiated and set the rates with the providers.188 Insurance companies
provide patients with freedom of choice. In addition, the insurance
companies’ coverage of clearinghouses’ services raises the issue that the
costs will shift or increase because patients will have to pay for more
expensive insurance on top of rising health care costs. There is also
uncertainty whether this method of price transparency will lower health
186. What is the Function of the Clearinghouse in Medical Billing?, DUMMIES,
https://www.dummies.com/careers/medical-careers/medical-billingcoding/what-is-the-function-of-the-clearinghouse-in-medical-billing/
#:~:text=The%20provider%20pays%20the%20clearinghouse,data%20int
erchange%20(EDI)%20number.&text=If%20the%20payer%20isn’t,the%2
0payer%20is%20enrolled%20with [https://perma.cc/H4EP-X5SW].
187. What is a Healthcare Clearinghouse & Why Use One?, NEARTERM BLOG
(Aug.
21,
2018),
https://nearterm.com/what-is-a-healthcareclearinghouse-medical-billing-electronic-claims/ [https://perma.cc/8T8KQRXY].
188. See Philip Moeller, 3 Problems That Are Spiking Health Care Costs,
According To This Surgeon, PBS NEWSHOUR: MAKING SENSE (Sept. 11,
2019, 6:03 am), https://www.pbs.org/newshour/economy/making-sense
/3-problems-that-are-spiking-health-care-costs-according-to-this-surgeon
[https://perma.cc/33GS-99C3] (discussing disclosure of costs that
“insurers and providers agree upon”).
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care costs. Although patients may pay more for insurance in the short
run, in the long run, this cost estimation process with clearinghouses
would overall likely improve price transparency and provide patients
the opportunity to shop for health care services and lower health care
costs.

Conclusion
Health care clearinghouses may be the solution to place patients in
the driver’s seat when it comes to their health care decisions.
Clearinghouses will release patients from the burden of analyzing online
pricing data and instead provide patients with straightforward cost
estimates that are specific to their insurance circumstances. The
implementation of a cost estimation process with health care
clearinghouses is complex. However, clearinghouses have the potential
to create the price transparency sought between health care providers
and patients, specifically for non-emergency medical circumstances. My
recommendation is to establish a broad framework involving health care
clearinghouses for a cost estimation system to improve price
transparency. Further research and cost-benefit analysis are necessary
to determine how to implement such a process. Nonetheless, if health
care clearinghouses provide patients with individualized cost estimates
and incentivize Americans to compare health care prices, then
clearinghouses may substantially improve health care price
transparency and reduce surging health care costs.
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